Capitalizing on natural experiments in low- to middle-income countries to explore epigenetic contributions to disease risk in migrant populations.
| Published in | Global Health, Epidemiology and Genomics, v. 1(E3) |
|---|---|
| Authors | Miranda, J., Weinhouse, C., Carrillo-Larco, R., & Yan, L. |
| Publication year | 2016 |
| DOI | https://doi.org/10.1017/gheg.2015.4 |
| IAI Program | CRN3 |
| IAI Project | CRN3036 |
| Keywords | |
Abstract
Migration poses a significant and worsening public health problem. As the world becomes increasingly interdependent and the global population continues to expand, rates of both within-country and international migration are rising. Migrants tend to experience differential risks for chronic disease, including cardiovascular and metabolic diseases [1&ndash7]. Differential health outcomes in international migrants are not limited to migrants from developing to developed countries migrants from one developed country to another with regional differences in chronic disease risk may be impacted, as well.